EULAV Asset Management’s Chemed CHE Stock Holding History

EULAV Asset Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,605	Closed	-$15.7M	–	134
2025 Q4	$15.7M	Sell	36,605 -58,600	-62%	-$25.5M	0.42%	76
2025 Q3	$42.6M	Sell	95,205 -28,313	-23%	-$12.8M	0.99%	31
2025 Q2	$60.1M	Buy	123,518 +19	+0%	+$10.8K	1.41%	24
2025 Q1	$76M	Hold	123,499	–	–	1.88%	13
2024 Q4	$65.4M	Hold	123,499	–	–	1.58%	18
2024 Q3	$74.2M	Hold	123,499	–	–	1.81%	14
2024 Q2	$67M	Buy	123,499 +12,100	+11%	+$6.93M	1.81%	14
2024 Q1	$71.5M	Buy	111,399 +7,800	+8%	+$4.74M	1.97%	12
2023 Q4	$60.6M	Buy	103,599 +24,200	+30%	+$13.5M	1.87%	13
2023 Q3	$41.3M	Hold	79,399	–	–	1.51%	15
2023 Q2	$43M	Hold	79,399	–	–	1.6%	11
2023 Q1	$42.7M	Hold	79,399	–	–	1.68%	14
2022 Q4	$40.5M	Sell	79,399 -3,301	-4%	-$1.61M	1.74%	13
2022 Q3	$36.1M	Sell	82,700 -7,700	-9%	-$3.7M	1.6%	14
2022 Q2	$42.4M	Sell	90,400 -3,300	-4%	-$1.61M	1.75%	13
2022 Q1	$47.5M	Sell	93,700 -1,700	-2%	-$815K	1.41%	16
2021 Q4	$50.5M	Hold	95,400	–	–	1.27%	21
2021 Q3	$44.4M	Hold	95,400	–	–	1.17%	21
2021 Q2	$45.3M	Hold	95,400	–	–	1.2%	25
2021 Q1	$43.9M	Hold	95,400	–	–	1.18%	26
2020 Q4	$50.8M	Hold	95,400	–	–	1.33%	15
2020 Q3	$45.8M	Sell	95,400 -2	-0%	-$981	1.35%	16
2020 Q2	$43M	Sell	95,402 -5	-0%	-$2.23K	1.41%	16
2020 Q1	$41.3M	Buy	95,407 +6,707	+8%	+$3M	1.65%	8
2019 Q4	$39M	Buy	88,700 +6,800	+8%	+$2.86M	1.34%	17
2019 Q3	$34.2M	Buy	81,900 +8,700	+12%	+$3.55M	1.26%	18
2019 Q2	$26.4M	Buy	73,200 +6,300	+9%	+$2.11M	0.99%	28
2019 Q1	$21.7M	Buy	66,900 +7,700	+13%	+$2.36M	0.89%	35
2018 Q4	$16.8M	Buy	59,200 +15,700	+36%	+$4.74M	0.84%	38
2018 Q3	$13.9M	Buy	43,500 +7,200	+20%	+$2.29M	0.6%	59
2018 Q2	$11.7M	Buy	36,300 +4,300	+13%	+$1.35M	0.54%	58
2018 Q1	$8.73M	Hold	32,000	–	–	0.42%	80
2017 Q4	$7.78M	Hold	32,000	–	–	0.37%	92
2017 Q3	$6.47M	Buy	32,000 +800	+3%	+$157K	0.31%	114
2017 Q2	$6.38M	Buy	31,200 +4,000	+15%	+$797K	0.31%	114
2017 Q1	$4.97M	Hold	27,200	–	–	0.25%	135
2016 Q4	$4.36M	Buy	27,200 +1,100	+4%	+$162K	0.23%	147
2016 Q3	$3.68M	Buy	26,100 +1,800	+7%	+$251K	0.19%	154
2016 Q2	$3.31M	Hold	24,300	–	–	0.18%	162
2016 Q1	$3.29M	Buy	24,300 +2,100	+9%	+$284K	0.18%	168
2015 Q4	$3.33M	Buy	22,200 +9,800	+79%	+$1.45M	0.18%	164
2015 Q3	$1.66M	Buy	+12,400	New	+$1.74M	0.09%	237

Other funds holding CHE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

EULAV Asset Management's CHE Position: Q1 2026 in Review

EULAV Asset Management sold out of Chemed (CHE) in Q1 2026, closing a stake of 36,605 shares — an estimated $15.7M sold.

EULAV Asset Management first reported a position in CHE in Q3 2015 and held it in 42 quarters. The position peaked at $76M in Q1 2025. 489 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

EULAV Asset Management reported no remaining Chemed position as of Q1 2026 after selling out during the quarter.
EULAV Asset Management sold 36,605 Chemed shares in Q1 2026, an estimated $15.7M.
EULAV Asset Management first reported a position in Chemed in Q3 2015 and held it in 42 quarters.
EULAV Asset Management's Chemed position peaked at $76M in Q1 2025.
489 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on EULAV Asset Management's 13F filing for Q1 2026, filed 7 May 2026.